The paraproteinemia is a disorder in which a single clone of plasma cells (monoclonal gammopathy) is responsible for the proliferation of monoclonal proteins (M-proteins). Approximately 10% of patients with idiopathic peripheral neuropathy have monoclonal gammopathy. Some M-proteins have the properties of an antibody to the components of peripheral nerve myelin, but the pathophysiological relationship between the neuropathy and the M-protein is often obscure. The relationship between peripheral neuropathy and monoclonal gammopathy requires the appropriate neurological and hematological investigations for precise diagnosis and treatment. In this review, we provide an update on the causal associations between peripheral neuropathy and monoclonal gammopathy as well as characteristics of clinical and electrophysiologic features. (Korean J Clin Neurophysiol 2015;17:45-52) 
The following conditions are being considered: 1) IgM paraproteinemic demyelinating neuropathy negative anti-MAG antibodies, or IgG or IgA paraproteinemic demyelinating neuropathy with a chronic progressive course, where the discovery of widely spaced myelin on electron microscopy or deposits of Ig and/or complement bound to myelin; 2) amyloidosis; 3) malignant lymphoproliferative infiltration of nerves are being considered. b Conventional X-rays to evaluate for lytic or sclerotic lesions must include a posterior-anterior view of the chest and films of the cervical,thoracic, and lumbar spines, humeri and femurs, skull, and pelvis. Part or all of this may be replaced by CT, which is more sensitive but involves greater radiation exposure except where low-dose whole body CT is available. If the index of suspicion is high, CT and/or MRI of the spine, pelvis, or whole body, and perhaps whole body FDG-PET/CT, may be considered. 
